rpv is a deep tech venture fund focused on early stage, scientifically intensive ventures.

The purpose of rpv is to drive tangible advancements in the well-being of humankind.

We do so by supporting outstanding people and providing them with capital, network, and expertise. We help scientists, entrepreneurs, and investors create value.

Our value system is based on two pillars: rigorous scientific method and strong ethical standards.

Our team is composed of reputable scientists, serial entrepreneurs and investment professionals. Our key areas of scientific expertise are Neuroscience, New Energy, Lasers, Additive Manufacturing and Advanced Materials

Arkady Kulik
Richard Silberstein
Paul Kewene-Hite
Serguei Netessinne
Sami Kizilbash
Dave McClure
Edward Jung
Eric Redmond
David Abashidze
Ramesh Srinivasan
Alexa Fedyukova
Alex Felman
Pete Jarvis
Chris Tolles
Mykhailo Marynenko

Teams We’ve Funded

Sanmai

Sanmai is led by Jay Sanguinetti – a top tier neuroscientist and pioneer of tFUS. This team has found a way to apply that type of neuromodulation to treat anxiety and depression.

1

Led by Yoav Zingher – an accomplished entrepreneur with a successful exit. Clients include Yamaha and Lockheed Martin.

2

Humanity Neurotech has developed a non- invasive way to manage brain inflammation. Applications are vast: from healing the consequences of long COVID or concussion to curing Glioblastoma and Alzheimer. Led by Blake Gurfein – a seasoned medtech executive who took his previous company from a theoretical concept to full FDA approval.

3

ViewMind’s test is noninvasive, 99% accurate, affordable, and takes 15 minutes. ViewMind’s SOM is $6B. Led by Mark Edwards – a technology executive with more than 25 years of experience.

4

PhotonVault is adding waste (or renewable sources) heat to amplify the energy storage output beyond what was taken from the grid. Led by Kent McCormick - PhD in Physics and an entrepreneur with a $140m exit.

5

Symbolic nature of their model allows them to scale costs linearly with training data, which means 700 times less compute demand than traditional LLMs. Led by Sergey Shumsky — one of the leading AI researchers, Paul Kewene-Hite — an experienced executive and entrepreneur, and Vamsi Sistla — 3X co-founder CTO and ex head of Data Science at Nike.

6

BIOS is building a universal neuro-electronic connector. Their tech enables two-way feedback for prosthetics with signal latency of less than 30ms. Breakthrough Device Designation is secured, as well as partnership with Mayo Clinic. Led by a trio of entrepreneur, neuroscientist and FDA expert.

7

AirTulip's patented technology creates a clean air zone around your head while you sleep. It cleans the air in the breathing zone up to a thousand times better than air purifiers. Led by Arjen de Jong – an aerodynamicist and serial entrepreneur, they have already shipped the first 100 headrests.

8

Tetmet develops architectured materials that use 70% less materials and 90% less energy than traditional analogues. They have produced the dashboard for the next luxury car concept and are in talks with a major European aerospace company about building seats for their planes. Led by Tom Vroemen – a successful repeat founder and Justin Dirrenberger – a renowned material scientist.

9

Studio 3e8 has found a way to 3D print metal orders of magnitude cheaper than the existing solutions. Capitalizing on their experience at MIT and Markforged, founding duo of Casey Johnsonw and Cassie Lowell is aspiring to make 3D printing of metals safe and accessible for everyone.

10

Malcova has created a pain-free way to detect breast cancer with 90%+ specificity. They have raised $6m in non-dilutive funding from the government, got 5 patents granted and are going into a 50 patient study led by Yale and Stanford.

11

Mimic is reducing the OPEX by 90% and doubling the efficiency of air conditioning by using the Peltier effect to cool and heat any indoor space. Berardo Matalucci is the founder with 15+ years of experience in this industry and is a classic “scientist turned entrepreneur” representative.

12

VoltAir is solving the challenge of the last mile cold storage delivery. By integrating the power unit, refrigeration, sensors and AI, they are achieving zero emission and reducing the costs by 60%. Founder Jumana Al Hashal, who honed her skills at Apple and Google, has impressed us with her passion and execution excellence.

13

ReBlood Rx has found a way to create a blood substitute that works across all blood types and is shelf stable for up to 2 years. It became possible thanks to their next-generation hemoglobin-based oxygen carriers (HBOCs). They are meticulously engineered to optimize resuscitation outcomes by tailoring its biophysical properties. ReBlood Rx has completed rodent studies and is doing the canine studies in 2025.

14

Laminar has created a wearable patch that non-invasively monitors blood flow and pressure. Their device leverages machine learning on the unique ultrasound hardware platform to automatically find arteries and measure doppler waveforms with a resolution and depth of penetration on par with $10,000 devices. Their ability to see hemodynamics enables: guided vascular procedures, continuous non-invasive BP, and early detection of worsening fluid state in CHF patients.

15

Icarus is developing solar-powered, autonomous stratospheric drones to provide persistent, high-resolution imagery and connectivity from the stratosphere. Their flagship platform, STRATOS, operates at altitudes above 20,000 km, offering wide coverage for live imaging and communication services. One drone like that is expected to replace 20 cell towers.

16

Mesomat has developed real-time sensors that measure road grip, tire wear, pressure, and temperature. This solution saves on average $2000 per year per vehicle by reducing tire wear, preventing blowouts and decreasing fuel used. It is particularly valuable for fleet operators, with the demand proven by pilots with UPS and Yokohama.

17

Brainflow has invented and patented a first-response device for stroke. Given the critical time sensitivity of a stroke, having such a device in ambulances doubles the chances of patient recovery compared to existing solutions. If successful, stroke will no longer be a damning condition for patients.

18

Vertility is our second investment in biotech, tackling genetic disease at the source with precision sperm sorting. Their approach ensures only healthy sperm are used, eliminating the risk of passing on genetic conditions. At ~8x cheaper than traditional IVF-based solutions, their method enables an accessible way to prevent genetic disease.

19